Antimicrobial Drug Resistance 2009
DOI: 10.1007/978-1-59745-180-2_18
|View full text |Cite
|
Sign up to set email alerts
|

Macrolides and Lincosamides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 53 publications
0
7
0
Order By: Relevance
“…One of the mechanisms of resistance to clindamycin involves acquisition of an erm gene (erythromycin ribosome methylase) usually carried on plasmids or transposons in pathogenic bacteria ( 19 ). Comparison of antimicrobial resistance levels in strains isolated 30 years apart (1970s and 2000) showed that Gram-negative Bacteroides species have acquired an ermB gene that originated in Gram-positive bacteria— Clostridium perfringens , Streptococcus pneumoniae , and Enterococcus faecalis ( 32 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One of the mechanisms of resistance to clindamycin involves acquisition of an erm gene (erythromycin ribosome methylase) usually carried on plasmids or transposons in pathogenic bacteria ( 19 ). Comparison of antimicrobial resistance levels in strains isolated 30 years apart (1970s and 2000) showed that Gram-negative Bacteroides species have acquired an ermB gene that originated in Gram-positive bacteria— Clostridium perfringens , Streptococcus pneumoniae , and Enterococcus faecalis ( 32 ).…”
Section: Discussionmentioning
confidence: 99%
“…These included four different antibiotic classes with different modes of action, antimicrobial spectra, and pharmacokinetic properties—a lincosamide (clindamycin), a quinolone (ciprofloxacin), a tetracycline (minocycline), and a penicillin (amoxicillin). Lincosamides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit and hence ultimately inhibit microbial growth ( 19 ). The lincosamide clindamycin has a broad spectrum of antimicrobial activity, including Gram-positive aerobes and anaerobes, Gram-negative anaerobes, and selected protozoa and fungi ( 20 ).…”
Section: Introductionmentioning
confidence: 99%
“…To date, 34 erm alleles have been identified and all but two have been reported in Gram-positive pathogens [18]. The classes of erm genes, erm(A) , erm(B) and erm(C ) are the most widely distributed in Gram-positive pathogens (Table 1) [19]. Distinctions between each erm class are based on bacterial host range and the MLS B resistance phenotype that is conferred.…”
Section: Induction Of Antibiotic Resistance Mediated By Ribosome-assomentioning
confidence: 99%
“…Distinctions between each erm class are based on bacterial host range and the MLS B resistance phenotype that is conferred. Each erm is predominantly associated with, but not limited to, one or two genera [18,19,201]; erm(A) is often associated with Staphylococcus , but has been reported in four other Gram-positive genera including Streptococcus and Enterococcus [20,21]; erm(B) is the prevalent determinant of MLS B resistance in streptococci but has been observed in 17 additional Gram-positive genera [18,201]. The most widely disseminated and clinically important determinant of MLS B resistance in Gram-positive pathogens is erm(C) , which has been identified in at least 13 Gram-positive genera, and is the predominant determinant of MLS B resistance in staphylococci [18].…”
Section: Induction Of Antibiotic Resistance Mediated By Ribosome-assomentioning
confidence: 99%
“…PM infection is often treated with antimicrobial agents that are efficacious in the respiratory tract, including cephalosporins, macrolides and lincosamides. Macrolides and lincosamides have the same mechanism of action and can also be used for the treatment of Mycoplasma species, Brachyspira hyodysenteriae and Lawsonia intracellularis 8–11 . The intensive administration of antimicrobials also facilitates the development of resistance through three main mechanisms: modification of target binding site, enzymatic inactivation of antimicrobials, and active efflux of antimicrobials 8 .…”
Section: Introductionmentioning
confidence: 99%